Buscar
Congreso SOLACI
Home Tags FFR

Tag: FFR

Functional Assessment of Coronary Stenoses: Hyperemic, Non-Hyperemic, and Angiographic Alternative Indices

Dr. Juan Manuel Pérez - 0

Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

Dr. Omar Tupayachi - 0

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

Dr. Omar Tupayachi - 0

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a...

Dr. Andrés Rodríguez - 0

FLAVOUR Trial Substudy: FFR or IVUS in the Assessment of Diabetic...

Dr. Carlos Fava - 0

FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs...

Dr. Andrés Rodríguez - 0

TCT 2024 | FAVOR III EUROPA

Dr. Carlos Fava - 0
FFR Post Angioplastia

Post PCI FFR

solaci - 0
Resonancia vs FFR en lesiones no culpables del infarto

MR vs. FFR in Non-Culprit Lesions

solaci - 0
La morfología de la placa podría modificar las mediciones funcionales

Plaque Morphology Could Modify Functional Measurements

solaci - 0
123...7Page 1 of 7

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad